Study of the Long-Term Safety of Pramlintide in Subjects With Type 1 Diabetes Mellitus

PHASE3CompletedINTERVENTIONAL
Enrollment

190

Participants

Timeline

Start Date

November 30, 2002

Primary Completion Date

June 30, 2005

Study Completion Date

June 30, 2005

Conditions
Diabetes Mellitus, Type 1
Interventions
DRUG

pramlintide acetate

Syringe vial and Pen-cartridge

Trial Locations (25)

Unknown

Research Site, Tempe

Research Site, Concord

Research Site, Fresno

Research Site, San Diego

Research Site, San Mateo

Research Site, Santa Barbara

Research Site, Walnut Creek

Research Site, Aventura

Research Site, Fort Myers

Research Site, New Port Richey

Research Site, Tallahassee

Research Site, Atlanta

Research Site, Indianapolis

Research Site, Detroit

Research Site, Grand Rapids

Research Site, City of Saint Peters

Research Site, Butte

Research Site, Durham

Research Site, Columbus

Research Site, Portland

Research Site, Camp Hill

Research Site, Nashville

Research Site, Irving

Research Site, San Antonio

Research Site, Renton

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY